Is ROIV Overvalued？
ROIV is now in the Fair zone, suggesting that
ROIV current forward PE ratio of -9.39 is considered
Fair compare with the five-year average of -6.96.
P/E
EV/EBITDA
P/S
P/B
P/E
P/E
ROIV Competitors Valuation Multiple
P/E
EV/EBITDA
P/S
P/E
P/E Multiple
Earnings Growth
Market Cap
ROIV Revenue Breakdown & PS Ratio Relation
Currency:USD
By Business
By Region
Composition (FY2025Q1)
Name
Revenue
Percentage
Biotechnology & Medical Research
55.13M
--
VTAMA
55.13M
--
ROIV FAQs
Is ROIV currently overvalued based on its P/E ratio?
According to the provided data, ROIV's 5-year historical average forward P/E ratio is -6.96. ROIV forward P/E ratio is -9.39, which is categorized as Fair.
What is the significance of the EV/EBITDA ratio for ROIV?
How has ROIV's Price to Sales (PS) ratio evolved?
What are the key indicators to watch for ROIV's financial performance?
ROIV PE Ratio
Fair
5Y Average PE
-6.96
Current PE
-9.39
Overvalued PE
-2.24
Undervalued PE
-11.69
ROIV EV/EBITDA Ratio
Fair
5Y Average EV
-3.10
Current EV
-2.40
Overvalued EV
-0.57
Undervalued EV
-5.64
ROIV P/S Ratio
Overvalued
5Y Average PS
53.33
Current PS
96.57
Overvalued PS
90.05
Undervalued PS
16.61
Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
At what price is ROIV undervalued？Is ROIV overvalued compared to its competitors？Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
At what price is ROIV undervalued？Is ROIV overvalued compared to its competitors？